Sanjana Saravanan

5PUBLICATIONS
31CO-AUTHORS
Cell and nuclear divisionCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityRadiation therapyMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 05, 2025
Substrate accessibility regulation of human TopIIa decatenation by cohesin.

Erin E Cutts, Sanjana Saravanan, Paul Girvan

|Mar 27, 2025
CD301b+ monocyte-derived dendritic cells mediate resistance to radiotherapy.

Sirimuvva Tadepalli, Derek R Clements, Hayley M Raquer-McKay

|Jul 06, 2023
Transitional dendritic cells are distinct from conventional DC2 precursors and mediate proinflammatory antiviral responses.

Fernando Bandeira Sulczewski, Raul A Maqueda-Alfaro, Marcela Alcántara-Hernández

|Jun 09, 2023
Rapid recruitment and IFN-I-mediated activation of monocytes dictate focal radiotherapy efficacy.

Sirimuvva Tadepalli, Derek R Clements, Sanjana Saravanan

|Feb 25, 2022
The Mitochondrial Genome in Aging and Disease and the Future of Mitochondrial Therapeutics.

Sanjana Saravanan, Caitlin J Lewis, Bhavna Dixit

Pageof 1

Frequent Collaborators

3 joint publications

Juliana Idoyaga

2 joint publications

Hayley M Raquer-McKay

2 joint publications

Sirimuvva Tadepalli

2 joint publications

Derek R Clements